论文部分内容阅读
目的 分析对于乳房巨大良性肿瘤患者,采用麦默通微创旋切术+小切口治疗的临床效果,并与传统手术治疗进行对比,观察其应用价值.方法 纳入2020年5月~2021年2月本院收治的76例乳房巨大良性肿瘤患者,均接受手术肿瘤切除术治疗.对76例患者依照双盲法分组,各38例,研究组患者实施麦默通微创旋切术+小切口手术,对照组采用传统手术,术后比较两组乳房形态满意情况、并发症等.结果 研究组瘢痕明显率仅为7.89%,显著低于对照组的81.58%,差异有统计学意义(P < 0.05);而研究组乳房形态满意度为97.37%,显著高于对照组的73.68%,差异有统计学意义(P < 0.05).研究组术后并发症发生率为2.63%,显著低于对照组的15.79%,差异有统计学意义(P < 0.05).结论 对乳房巨大良性肿瘤患者采用麦默通微创旋切术+小切口手术治疗,术后并发症少,且美容效果更佳.“,”Objective To observe the effect of traditional surgical methods, Mammotome minimally invasive atherectomy + small incision treatment in the resection of huge benign breast tumors. Methods From May 2020 to February 2021, 76 patients with huge benign breast tumors were enrolled in our hospital, all of whom underwent surgical tumor resection. According to the hospitalization number, 38 patients in the control group received traditional surgical treatment, and 38 patients in the study group received Mammotome minimally invasive atherectomy + small incision surgery. The surgical effects of the two groups were compared. Results The apparent scar rate in the study group was only 7.89%, which was significantly lower than 81.58% in the control group, and the difference was statistically significant(P<0.05); while the breast shape satisfaction rate in the study group was 97.37%, which was significantly higher than 73.68% in the control group. The difference was statistically significant (P<0.05). The postoperative complication rate in the study group was 2.63%, which was significantly lower than 15.79% in the control group, and the difference was statistically significant (P<0.05). Conclusion Mammotome minimally invasive atherectomy + small incision surgery is used for patients with huge benign breast tumors, with fewer postoperative complications and better cosmetic results.